Aneurysm
Conditions
Brief summary
The purpose of the registry is to evaluate the peri-operative and short-, mid- and long-term outcomes of the Bard Covera Plus (Tempe, Arizona, USA) for the treatment of atherosclerotic aorto-iliac aneurysm in combination with a multibranched endograft
Interventions
DEVICEcovered stent
atherosclerotic aorto-iliac aneurysm
Sponsors
IRCCS San Raffaele
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult patients ≥18 years * Patients who underwent/will undergo a complex aortic procedure with the use of a Covera Plus covered stent graft as a bridging stent, in the centres involved in this Registry * Subject has consented for study participation and signed the approved Informed Consent
Exclusion criteria
* Bleeding diathesis or coagulopathy * Patients with active systemic or cutaneous infection or inflammation * Patients who are pregnant or lactating * Patient younger than 18 years of age * Patients who did not receive treatment using a Covera Plus covered stent graft.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| technical success | 30 days | freedom from type I or type III endoleak, stenosis/occlusion, dislocation/kinking |
| Branch instability | 30 days | freedom from branch-related complications |
| Primary clinical success | 30 days | freedom from death, type I/III endoleak, graft infection/thrombosis, aneurysm expansion and/or rupture, conversion to open repair, or new treatment-related thoraco-abdominal pathologies |
Countries
Germany, Italy
Outcome results
None listed